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Objective: The aim of this study was to investigate the clinical value of serum measurement of C-telo-
peptide of type II collagen (CTX-II). In correlation with late stages of osteoarthritis (OA) evaluated with
histological assessment, the evolution of serum CTX-II concentration was followed during a 20-week
longitudinal study in rabbit anterior cruciate ligament transection (ACLT) OA model in adult and growing
animals.
Methods: OA was induced in ﬁve adult and nine growing rabbits. Four adult and four young rabbits were
unoperated. Serum sampling was made at week 0, 1, 2, 3, 4, 6, 8, 10, 12, 14, 16 and 20 after the surgery in
all rabbits. Animals were euthanized 20 weeks after the surgery. Serum CTX-II levels were analyzed with
a recently available enzyme-linked immunosorbent assay (ELISA) kit, the protocol of which has been
modiﬁed to increase the sensitivity of the test.
Results: Signiﬁcant differences for the CTX-II levels at W3, W6, W8, W10, W12, W14, W16 and W20 were
observed between the adult ACLT and the control groups. A negative correlation between CTX-II levels
and cartilage thickness of the medial compartment of the knee at W8, W10, W12 and a positive
correlation between the CTX-II levels and the histomorphological score of the medial compartment of
the knee at W3, W6, W8, W10, W12 were noted in adult animals. In young animals, operated or not, we
observed high CTX-II levels at the beginning of the study, which decreased until the end.
Conclusion: Our results suggest the interest of the serum CTX-II monitoring for the OA progression and
the relevance of the multiple time point analysis of this biomarker. Moreover, they address the question
of the importance of correctly choosing the age of the animals used in the pre-clinical studies of OA.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a disease characterized by a progressive
destruction of articular cartilage and by pathological changes in the
subchondral bone and synovial membrane1. A major concern in
clinical trials in human studies is the improvement and develop-
ment of diagnostic tools and a more sensitive monitoring of the
disease progression2e6. Several papers have reviewed the potential
of biomarkers of OA as they provide information on early cellular
and molecular tissue changes2,3,7,8.Marie-Eve Duclos, Université
ractions biologiques et bio-
Cedex 08, France. Tel: 33-6-
clos).
s Research Society International. PIn OA, the destruction of the articular cartilage will result in the
loss of its two major components, proteoglycans and type II
collagen, making them markers of choice in the evaluation of
cartilage metabolism8. In humans, the degradation products of
type II collagen have been studied in numerous studies9,10. Among
them, C-telopeptide of type II collagen (CTX-II) is one of the most
studied markers7,10. Elevated levels were demonstrated in patients
with OA compared with asymptomatic subjects or without
radiographic signs of OA11e15. Some papers have shown a signiﬁ-
cant association between radiographic progression of OA and CTX-
II concentration13,16e18. A more recent study has shown the
predictive value of urinary levels of CTX-II for the loss of cartilage
assessed by MRI19.
Many animal models are available to study the pathogenesis of
OA and to evaluate the efﬁcacy of drugs with anti-OA potential20,21.
Although the standard references for quantifying the development
of OA are the macroscopic and microscopic analysis, some studies
have focused on the quantiﬁcation of biomarkers in several animalublished by Elsevier Ltd. All rights reserved.
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that the time of the trauma remains known, but the exact onset of
molecular events of early OA following trauma is still incompletely
understood. As biological ﬂuid (synovial ﬂuid, urine or serum) can
be obtained before and after the joint injury, biomarkers can be
measured in order to precise early molecular events of OA. In an OA
rodent model, cartilage matrix breakdown was demonstrated
during the early stages of OA progression and a positive correlation
between urinary CTX-II levels and histological scores was
described27. The results of that study also assessed age-related
changes in cartilage turnover in rats and showed a stabilization of
cartilage around 5e7 months old.
Only, two studies have been published on biomarkers of OA in
adult rabbits. Felice et al.28 showed a rapid rise in the degradation of
cyanogen bromide cleavage peptide 9.7 (CB 9.7) in synovial ﬂuid
with the HultheTelhag model. Lindhorst et al.29 assessed synovial
ﬂuid Col2CTx levels, another marker of type II collagen (which
measures the same epitope than CTX-II but with different anti-
bodies) in a menisectomy rabbit model. Their results showed that
this marker could be useful in the evaluation of early pathological
changes of OA.
The transection of the anterior cruciate ligament (ACLT) in
rabbits leads to rapid development of OA. This animal model has
been well characterized at both macroscopic and microscopic
levels30,31 but data are lacking regarding its molecular
characterization.
Recently, a CTX-II kit assay adapted for serum and synovial ﬂuid
analysis in animals has been developed by Oestergaard et al.22. In
a rodent model with intra-articular injections of mono-iodoace-
tate32, they found strong association between microscopic severity
scores and CTX-II levels in synovial ﬂuid but not in serum. To our
knowledge, no data are available regarding the use of this kit in
rabbit sera and about cartilage turnover in young and adult animals.
In contrast with urine or synovial ﬂuid, serum sampling do not
require animal anesthesia and represents a method less invasive to
obtain biological ﬂuid.
The aim of this study was to investigate the clinical value of
serum measurement of CTX-II. The evolution of CTX-II concentra-
tion was followed during a 20-week longitudinal study in rabbit
ACLT OA model in both adult and growing animals and correlated
with histological assessment at the end of the experiment where
OA process was always at an advanced stage.Material and methods
Experimental animal model
Twenty-seven healthy male New Zealand White rabbits were
used in the study. Twelve rabbits were skeletally mature (10-
month-old) and weighing 5.27 0.25 kg; 15 were growing (2-
month-old) weighing 2.03 0.15 kg kg (mean SD). After 15 days
of acclimation, experimental OA was surgically induced by ACLT in
the left knee: the operated groups were composed of eight adult
rabbits and ten young rabbits. Five young and four adult rabbits
were unoperated and formed the control groups. The large
disparity in group sizewas due to themortality of some animals (no
biological test was done but the clinical features suggested pas-
terellosis signs) at their arrival and it is also more difﬁcult to ﬁnd
adult animals than young animals. Animals were housed during the
same period at the Institut Claude-Bourgelat, Lyon. They were kept
in individual cages (80 cm 80 cm 60 cm, webbed ﬂooring). All
experiments were conducted in full compliance with Ecole Natio-
nale Vétérinaire de Lyon Ethical Committee Guidelines (protocol
agreement no. 0634).Surgical procedure
Analgesiawas providedwithmorphine (Aguettant, Lyon, France)
before (3 mg/kg) and after surgery (2 mg/kg). Fentanyl patch (25 mg/
h, Durogesic, Janssen-Cilag, Issy-les-Moulineaux, France) was
placed on the interscapular space for 3 days following surgery.
Trimethoprim 4% (v/w) and Sulfadiazine 20% (v/w) (20 mg/kg,
Borgal, Intervet, Whitby, Canada,) were administered preopera-
tively and twice a day for 4 days post-operatively. Operated rabbits
were ﬁrstly anesthezied by an intramuscular injection of ketamine
(35 mg/kg, Imalgène 1000, Merial, Lyon, France) and xylazine
(2 mg/kg, Rompun 2% (v/w), Bayer HealthCare, Gaillard, France).
Anesthesia for the surgical procedure was then maintained with
a mixture of isoﬂurane in oxygen. A lateral parapatellar arthrotomy
was performed under sterile conditions. The patella was dislocated
medially and the knee placed in full ﬂexion. The ACL was visualized
and sectionedwith a no.12 blade. The jointwas irrigatedwith sterile
saline and closed. The contralateral knee was left intact. Rabbits
were allowed free activity in their cages. The animals were closely
monitored for infections and other complications by a veterinarian.
Body weights were measured twice a month. The unoperated and
operated anesthesied rabbits were euthanized 20 weeks post-
surgery by intracardiac injection of sodium pentobarbital eutha-
nasia solution (Dolethal, Vétoquinol, Lure, France). Although it is
known in this model that advanced disease (ulceration of cartilage)
is already present 12weeks after the surgery in themajority of adult
animals,wechosea longer study timebecause theprogressionof the
disease in young animals is not precisely known and we were
interested to follow CTX-II evolution before and after the ulceration
development in both age groups of animals.
Blood sampling
5 mL of blood samples were collected serially from the central
ear artery of each rabbit at 0,1, 2, 3, 4 6, 8,10,12,14,16 and 20weeks
post-surgery. Blood samples were centrifuged at 3000 RPM for
12 min and sera stored in 250 mL aliquots at 80 until CTX-II assay
were performed.
CTX-II assay
Serum level of CTX-II was measured over time with the
commercially available Serum Pre-clinical Cartilaps enzyme-linked
Immunosorbent assay (ELISA) (Nordic Bioscience, Herlev, Denmark)
according to the manufacturer’s instructions with some modiﬁca-
tions for the rabbit adult samples. Brieﬂy, the sandwich ELISA
employsmonoclonal antibody F4601 speciﬁc for the EKGPDP amino
acid sequence derived from the CTX-II. Since the kit lacks sensitivity,
we changed serum and buffer volumes in eachwell for adult rabbits
during the primary incubation: 50 mL of bufferwere added to 100 mL
of sample instead of 100 mL of buffer with 25 mL of sample. We also
modiﬁed some of the incubation times: primary and secondary
incubations were extended to 90 min. Incubation time with chro-
mogenic substrate solution was extended to 30 min. We analyzed
ﬁve identical serum samples three times in a same kit and with ﬁve
different kits to evaluate the intra- and inter-assay variations.
Cartilage macroscopic assessment
The articular cartilage of the femur and the tibia were graded
blindly according to the following criteria: normal appearance,
ﬁbrillation, ﬁssuration, ulceration (illustrated in Fig. 1). After the
application of diluted India ink, we graded the lesions according to
their size30,33,34: Grade 0: normal in appearance and does not retain
India ink; Grade 1: 0 mm< ﬁbrillation 4 mm; Grade 2:
Fig. 1. Macroscopic articular cartilage, stained with India ink, representative of different kinds of macroscopic lesions. A: Normal cartilage, no uptake of India ink; B: ﬁbrillation in
lateral femoral condyle (minimal uptake of India ink, with surface irregularities) and ﬁssuration (evident dark patches of ink uptake) in medial femoral condyle; C: ﬁssuration in
lateral femoral condyle and ulceration (area demonstrating visible bone) in medial femoral condyle; D: ulceration in both femoral condyles.
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0 mm< ﬁssuration 4 mm; Grade 5: 4 mm< ﬁssuration 8 mm;
Grade 6: 8 mm ﬁssuration; Grade 7: 0 mm< ulceration 2 mm;
Grade 8: 2 mm< ulceration 5 mm; Grade 9: 5 mm< ulceration.
The lesions were documented digitally using a Panasonic DMC-LZ5
camera. The results are presented using medial (both medial femur
and tibia) and lateral knee scores (both lateral femur and tibia) and
by the total knee score (meanof bothmedial and lateral knee scores).Cartilage histological assessment
The distal part of the femur and the proximal part of the tibia
were ﬁrst ﬁxed in 10% (v/v) buffered formalin solution for 24 h.
Each femoral condyle and tibial plateau were cut in 3 mm-thick-
ness sagittal sections through the weight-bearing surface with
a low speed Isomet saw (Buehler, Illinois, USA) and 15 HC diamond
blade (10.2 0.3 mm). The ﬁxation was then completed with three
different successive baths for 1 week of 80% ethanol. Dehydratation
and embedding were made according to previously described
histological procedure35. Undecalciﬁed sections (8 mm-thickness)
of the femoral condyles and tibial plateaus were cut with a Polycut
E microtome (Leica Microsystem, Wetzlar, Germany) starting from
medial part of each knee compartment (lateral and medial femoral
condyle, and medial and lateral tibial plateau). Two non-consecu-
tive sections were evaluated per knee compartment. Although
more non-consecutive sections are generally recommended to have
a better picture of the joint, we needed the remaining bone samplesfor performing microradiography. Sections were stained by the
Safranine O-light green and Goldner trichrome stainings.
Histological assessment wasmadewith a scoring system adapted
from Mankin and Colombo score systems on Safranin O-light green
staining36e38. Four parameters were evaluated: degree of staining,
cartilage structure, chondrocytes density and clone formation (Fig. 2).
Cartilage thickness was expressed in micrometers and
measured at a 12.5 magniﬁcation for each compartment. It was
measured with Goldner trichrome staining at the site where the
worst lesions are normally found for each articular surface. Carti-
lage surface was delimited manually. Software calculated cartilage
thickness by dividing area by the length of the delimited cartilage.
When whole analysis area was ulcerated, none delimitation was
done and cartilage thickness was 0 mm. When analysis area pre-
sented both cartilage and ulcerated zones, the cartilage thickness of
the cartilage zone was ﬁrst calculated. Then a mean between the
cartilage thickness of the two zones was calculated according to the
length proportion of each other. Only one analysis was performed
for a given sample. However, ﬁve different analysis separated each
other of 1 week, with 16 different samples was performed and the
variation coefﬁcient for the cartilage thickness was calculated.
Each histological result represents the mean of score or cartilage
thickness of two non-consecutive histological sections obtained by
articular compartment. These results are presentedusing themedial
(both medial femur and tibia) and lateral (both lateral femur and
tibia) knee compartment scoresor the total knee score (meanofboth
medial and lateral knee scores) for both histomorphological
assessment and cartilage thickness measurements.
Fig. 2. Representative histological sections stained with Safranin O-light green and illustrating cartilage lesions. A: Normal articular cartilage with intact surface of a lateral tibia,
Magniﬁcation 12,5; B: Loss of cartilage matrix49 and ﬁbrillation in a medial femur, Magniﬁcation 50; C: Clusters of cells in a ﬁbrillation with loss of Safranine O-light green
staining lesion in a medial femur, Magniﬁcation 200; D: Erosion of cartilage matrix to subchondral bone in a medial femur, Magniﬁcation 25; E: Junction between both ulceration
and cartilage zones medial femur, Magniﬁcation 50.
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All analyses were planned to be performed at 5% signiﬁcance
level. For the macroscopic and histological assessment, compar-
isons between animal groups were made with nonparametric
ManneWhitney test for unpaired observations. The evolution of
CTX-II and weight over time between groups was assessed using
a two-way repeated measures analysis of variance. Associations
between histology data and CTX-II levels were made with
Spearman’s rank correlation coefﬁcient. Analyses wereperformed with a statistical package software (StatView, SAS
Institute, Version 5.0).
Results
Validation of the kit modiﬁcations
Figure 3 shows standard curves derived from both normal and
modiﬁed protocols. A shift of the modiﬁed curve to the left was
observed, resulting to a dynamic range of the curve between
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Fig. 3. Standard curves in the normal and modiﬁed protocols for the measurement of CTX-II.
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assay was 3.2% and 6.3% for intra- and inter-assay variations
respectively.
Clinical evaluation
According to the clinical examination some rabbits were taken
out of the study: three rabbits from the adult operated group were
withdrawn due to the integrity of their articulation (oedema,
suspicion of septic arthritis), one rabbit from the young operated
group and one rabbit from the young unoperated group for bad
general health reasons.
Weight loss occurred in the adult operated animals while the
unoperated group showed stable weight during the study. Weight
evolution showed a signiﬁcant difference between the ACLT adult
rabbits and the control group during the study (P< 0,001). With
regard to the young rabbits, no signiﬁcant difference in the weight
was observed over time between ACLT and control groups
(P¼ 0,637). Their weight increased with age, but did not reach the
initial body weight of the adult rabbits (P¼ 0.02). Table I shows the
weight progression over time.
Macroscopic assessment
At the time of sacriﬁce, gross evaluation showed more severe
changes in operated group, in comparison to the unoperated
rabbits (total knee score: P¼ 0.014 for the adult group and P¼ 0.02
for the young group). No difference was found between the adultTable I
IWeight evolution for each rabbit group taken every 4 weeks (N¼ 5 for the operated adu
N¼ 4 for the unoperated young group). Values are expressed as means, with the 95% co
Group Weight (kg) Weight evolution (mean sd) (kg)
Week 0 Week 4 Week
Operated adult rabbits 5.14 (5.03e5.26) 4.74 (4.51e4.96) 4.67 (
Unoperated adult rabbits 5.42 (4.93e5.91) 5.33 (4.85e5.81) 5.12 (
Operated young rabbits 1.98 (1.91e2.05) 2.54 (2.42e2.66) 3.06 (
Unoperated young rabbits 2.15 (1.82e2.47) 2.64 (2.36e2.92) 2.91 (and young rabbits in the control group. Otherwise, the macro-
scopic analysis revealed more severe changes in the adult oper-
ated group, compared to the young operated animals (total knee
score: P¼ 0.003). Table II summarizes the macroscopic results.
Histopathological evaluation
Microscopic analysis showed higher score in the operated
group, in comparison to the unoperated in both age groups (mean
with 95% conﬁdence intervals): 12.28 (9.28e15.28) for the adult
operated group and 1.75 (0.48e3.03) for the unoperated adult
group (P¼ 0,014) (Fig. 4); 7.53 (5.93e9.13) for the operated young
group and 1.72 (0.23e3.67) for the unoperated young group
(P¼ 0,006) (data not shown). No difference was found between
adult and young rabbits in the control group (P¼ 0,89). Otherwise,
the microscopic evaluation revealed signiﬁcant higher score for the
adult operated rabbits, compared to the young operated rabbits
(P¼ 0.03).
Despite the small size of the animal groups, the mean cartilage
thickness for the total knee of operated adult rabbits was signiﬁ-
cantly lower than control adult rabbits (respectively, 281.51
(125.00e427.30) mm and 436.84 (339.30e534.34) mm, P¼ 0.050,
Fig. 5) whereas the mean cartilage thickness of operated young
rabbits was higher than the control young rabbits (respectively,
505.00 (462.40e547.81) mm and 409.06 (324.42e493.69) mm,
P¼ 0.45). No difference was found between adult and young
rabbits in the control groups by contrast to operated groups
(P¼ 0.003).lt group; N¼ 4 for the unoperated adult group; N¼ 9 for the operated young group;
nﬁdence intervals
8 Week 12 Week 16 Week 20
4.46e4.87) 4.70 (4.48e4.92) 4.84 (4.63e5.05) 4.80 (4.61e4.98)
4.60e5.65) 5.38 (4.80e5.95) 5.55 (5.16e5.94) 5.60 (5.14e6.05)
2.87e3.25) 3.41 (3.17e3.66) 3.63 (3.37e3.89) 3.83 (3.58e4.08)
2.49e3.34) 3.30 (2.70e3.89) 3.45 (2.91e4.00) 3.69 (3.04e4.34)
Table II
IIMacroscopic score for each rabbit group presented for the lateral, medial and total
knee (N¼ 5 for the operated adult group; N¼ 4 for the unoperated adult group;
N¼ 9 for the operated young group; N¼ 4 for the unoperated young group). Values
are expressed as means, with the 95% conﬁdence intervals
Group animals Macroscopic score (95% conﬁdence intervals)
Medial knee Lateral knee Total knee
Operated adult rabbits 8.03
(5.58e10.49)
5.57
(2.09e9.05)
6.8
(5.32e8.28)
Unoperated adult rabbits 2.63
(0.64e4.61)
0.88
(0.33e1.42)
1.75
(0.51e3.00)
Operated young rabbits 3.30
(2.45e4.15)
3.35
(1.36e5.34)
3.32
(2.38e4.27)
Unoperated young rabbits 2.38
(1.50e3.25)
0.67
(0.36e0.98)
1.52
(1.074e1.97)
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histological assessment
As we observed some differences of the CTX-II level evolution
between adult and young rabbits, results will therefore be pre-
sented separately (Fig. 6).
Adult rabbits
A slight decrease of CTX-II levels was observed with the unop-
erated adult rabbits from the beginning of the study until week 6
(W6) post operation, followed by a mild increase until W12, then
a second decrease and stabilization of CTX-II level during the last
month of the study [Fig. 6(A)]. The CTX-II evolution showed two
distinct elevations with ACLT rabbits, one during the three ﬁrst
weeks after the surgery, followed by a decrease until the W4 and
a second peak at the W12. From the peak of the W12, a decrease
was observed until the end of the study. Statistical analysis showed
that CTX-II levels can differentiate operated from unoperated
animals.
We observed a positive correlation between the CTX-II levels at
W3 (r0¼0.78, P¼ 0.03), W6 (r0¼0.78, P¼ 0.03), W8 (r0¼0.76,
P¼ 0.03), W10 (r0¼0.63, P¼ 0.03) and W12, and the histomorpho-
logical score of the medial compartment [Fig. 7(A)]. Our results
showed negative correlation between the CTX-II levels at W8
(r0 ¼ 0.82, P¼ 0.02), W10 (r0 ¼ 0.70, P¼ 0.048) and W12 and the
cartilage thickness of the medial compartment [Fig. 7(B)]. Non-
signiﬁcant correlationwas found between CTX-II levels at W20 and
histological analysis of the medial compartment of the knee [Figs. 7
(C) and 7(D)].
Young rabbits
With young rabbits, CTX-II levels were quite high (224118 pg/
mL, Fig. 6(B)) at the beginning of the study and decreased over timeOperated Unoperated
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Fig. 4. Histomorphological score of ACLT and unoperated adult rabbits for the medial (A), l
quartiles and the smallest and largest observations. N¼ 5 for the operated group and N¼ 4until the end of the experiment. Time (associated to the animal
growth) affected CTX-II levels (P< 0,001), but not the chirurgical
act. The CTX-II levels decreased with growth, but did not reach the
initial basal level of the adult rabbits group (P¼ 0.03).
No correlation between the macroscopic or the microscopic
analyses and the CTX-II level evolutionwas found at any time point
in the young rabbits group.
Discussion
In the present study we investigated the articular cartilage
degradation with the measurement of serum CTX-II levels in a 5-
month longitudinal study with an ACLT surgical model. To our
knowledge, this study presents the ﬁrst results from a longitudinal
evaluation of CTX-II marker with an OA rabbit model. Macroscopic
and microscopic analyses showed typical OA lesions in all the
operated rabbit knees.
The ﬁrst CTX-II peak appeared during the ﬁrst three weeks
following the surgery. That joint response seems to be associated
with post-operative inﬂammation in the joints due to the chirur-
gical act which can inﬂuence cartilage collagen turnover. The fact
that the CTX-II levels decreased in the operated rabbits after the
initial rise and before the second one conﬁrms this hypothesis.
Other studies reported the same early collagen type-II degradation
in operated and sham-operated knee joints in rabbits using
immunohistochemistry39 and measurement of Col2CTx in synovial
ﬂuid29. Lohmander et al. found an increase of CTX-II in synovial
ﬂuids of patients tested soon after a knee injury40. In their study,
they observed that increased CTX-II levels were accompanied by
the release of aggrecan fragments and MMPs.
From the sixth week on, we observed a second rise of CTX-II
continuing up to a peak at W12 for the majority of animals (peak at
the fourteenth week for one animal), followed by a progressive
decrease until the end of the study. Those results suggest that
enhanced degradation seems to occur 6 weeks after the surgery in
the progression of the OA disease, followed by a moderate degra-
dation in later stages due to a reduction in cartilage volume. CTX-II
peak might be associated with the presence of an ulcer lesion with
a high cartilage destruction activity. It was shown that light OA
lesions were present 4 weeks after the surgery while around 40%
and 60% of the animals presented cartilage ulcer lesions in the load
bearing area at W8 and the W12 respectively after the surgery30.
The following fall in the CTX-II level suggests that there was no
more cartilage in the load bearing area during the late stage of the
OA progression and thus less production of marker in the joint. In a
5-year longitudinal study in humans, Sharif et al. reported
a progressive CTX-II rise during the two ﬁrst years followed by
a decrease during the three following years with patients classiﬁed
in a OA progressive sub-group16. The evolution of the CTX-II
concentration that we found with the operated adult rabbits
demonstrates the relevance of a multiple time point analysis. FromUnoperated Operated Unoperated
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ateral (B) and total (C) knee compartments. Box plots show the median, ﬁrst and third
for the unoperated group.
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Fig. 5. Cartilage thickness of ACLT and unoperated adult rabbits for the medial (A), lateral (B) and total (C) knee compartments. Box plots show the median, ﬁrst and third quartiles
and the smallest and largest observations. N¼ 5 for the operated group and N¼ 4 for the unoperated group.
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cartilage activity and the stages of OA lesions could be obtained.
In order to evaluate the OA predictive value of CTX-II, we per-
formed correlations between CTX-II levels at all time points and
microscopic assessments at the end of the study. We showed
a negative correlation between CTX-II levels at W8, W10 and W12
and cartilage thickness of medial compartment of the knee.
Moreover, a positive correlation between CTX-II levels at W3, W6,
W8, W10 and W12 and histomorphological score of the medial
compartment of the knee was observed. These results are in
accordance with others, which showed predominant lesions in the
medial knee compartment with this animal model30,31. They
suggest that serum CTX-II has predictive value for the disease
severity and cartilage loss in the ACLT rabbit model during the OA
process. Even if the rise at the third week appears to be associated
to the surgery, it seems to be predictive of late disease stage, as
evidenced by the correlation between the CTX-II levels at this time
and the histomorphological score. In this context, early CTX-II
analysis could be interesting for evaluating the late cartilage
damage following the joint trauma. The lack of association between
CTX-II levels at W16 and W20 and histological assessment may be
due to low levels of CTX-II at those times, which were close to
concentrations measured in control animals. This suggests that
CTX-II levels, at terminal stages of OA, must be interpreted with
caution and exempliﬁed the interest to make measurements of the
marker at several time points.
In young operated rabbits as well as in unoperated animals, our
results showed high CTX-II levels (around 20-fold comparatively to
adults), decreasing all along the study until the end. Those high
levels of CTX-II seem to be representative of the growth plate
activity, which decreases with the animal growth. This activity
seems to inﬂuence the cartilage turnover until 11e12months of age
in rabbits. Other animal studies found that cartilage turnover is0 2 4 6 8 10 12 14 16 18 20
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Fig. 6. Evolution of serum CTX-II levels in adult (A: N¼ 5 for the operated group and N¼ 4 f
for the unoperated group). Data are shown as mean and bars represent 95% conﬁdence intinﬂuenced by the growth in young rats until 5e7 months of
age27,41,42. In humans, high concentrations were also seen in chil-
dren, adolescent and young adults (aged of 20e25 years old) and
stable levels were detected in adults between 30 and 50 years
old11,43. Our results point out the interest of the use of the CTX-II as
a marker of the turnover of the growth plate, as it had been already
shown for COMP44,45.
Results of OA lesions that were found in the young operated
rabbits indicate a progression of the disease slower than that
observed in adult rabbits, young animal having a higher compen-
sation capacity of the cartilage46. Indeed, only two of the nine
young operated rabbits presented two small ulcers in one of these
articular compartments 20 weeks after the ACLT surgery by
comparison with the operated adult rabbits, where at least one
cartilage ulcer with average size in one of its compartments joints
was always observed. Vignon et al.29 reported that 11 rabbits on 36
animals, weighing 1.8e2.5 kg, presented cartilage ulcer 12 weeks
after ACLT surgerywhile Yoshioka et al.30 showed that six rabbits on
10, weighing around 4.4 kg, presented cartilage ulcer 12 weeks
after ACLT surgery.
Differences in the macroscopic/microscopic results and the
evolution of CTX-II during time between the operated young and
adult rabbits question the use of young animals in OA studies. The
articular cartilage of the knee of the New Zealand rabbits reaches
structural maturity at the time of their sexual maturity (3e4
months) but the growth plates are still opened and active at that
time47 until the animal is 7e8 months old48. Our results suggest
thus that thematurity of the articular cartilage is not the only factor
which affects the progression of the OA lesions.
In conclusion, our results demonstrate the interest of the serum
determination of CTX-II for the monitoring of the OA progression.
Other studies with a greater number of animals and multipoint
histological assessment will bring additional information on the0 2 4 6 8 10 12 14 16 18 20
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or the unoperated group) and young rabbits (B N¼ 9 for the operated group and N¼ 4
ervals.
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Fig. 7. Correlations between CTX-II levels at the twelfth (upper graphs) and twentieth (bottom graphs) weeks and histomorphological score (A or C) cartilage thickness (B or D) in
the medial compartment of the knee. N¼ 9.
M.E. Duclos et al. / Osteoarthritis and Cartilage 18 (2010) 1467e14761474predictive value of this marker. Finally, our ﬁndings address the
question of the importance of carefully choosing adults animals
used in the pre-clinical studies of OA.Author contributions
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